Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/10/16 → 4/15/21 |
Funding
- ICON Clinical Research, LLC (Prot #R475-PN-1524 // Prot #R475-PN-1524)
- Regeneron Pharmaceuticals, Inc. (Prot #R475-PN-1524 // Prot #R475-PN-1524)
Prot #R475-PN-1524: A Randomized, Double-blind, Multi-dose, Placebo-controlled Phase 2/3 Study to Evaluate the Efficacy and Safety of Fasinumab in Patients with Moderate to Severe Chronic Low Back Pain
- Schnitzer, Thomas J (PD/PI)
Project: Research project